GPR137B

gene
On this page

Summary

GPR137B (G protein-coupled receptor 137B, HGNC:11862) is a protein-coding gene on chromosome 1q42.3, encoding Integral membrane protein GPR137B (O60478). Lysosomal integral membrane protein that regulates the localization and activity of mTORC1, a signaling complex promoting cell growth in response to growth factors, energy levels, and amino acids.

Involved in positive regulation of TORC1 signaling; positive regulation of protein localization to lysosome; and regulation of autophagy. Located in lysosomal membrane.

Source: NCBI Gene 7107 — RefSeq curated summary.

At a glance

  • GWAS associations: 6
  • Clinical variants (ClinVar): 61 total — 2 pathogenic
  • MANE Select transcript: NM_003272

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:11862
Approved symbolGPR137B
NameG protein-coupled receptor 137B
Location1q42.3
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000077585
Ensembl biotypeprotein_coding
OMIM604658
Entrez7107

Gene structure

Transcript identifiers

Ensembl transcripts: 13 — 10 protein_coding, 1 retained_intron, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined

ENST00000366591, ENST00000366592, ENST00000419162, ENST00000454895, ENST00000477559, ENST00000889782, ENST00000889783, ENST00000889784, ENST00000889785, ENST00000889786, ENST00000972103, ENST00000972104, ENST00000972105

RefSeq mRNA: 1 — MANE Select: NM_003272 NM_003272

CCDS: CCDS1609

Canonical transcript exons

ENST00000366592 — 7 exons

ExonStartEnd
ENSE00000961594236168706236168755
ENSE00001022688236208050236208907
ENSE00001442134236142539236143036
ENSE00003465477236205126236205250
ENSE00003577777236178414236178636
ENSE00003694495236183778236183906
ENSE00003741263236179879236180028

Expression profiles

Bgee: expression breadth ubiquitous, 283 present calls, max score 96.81.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 32.0933 / max 411.4252, expressed in 1723 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
921530.84201720
92141.2514792

Top tissues by expression

294 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
pigmented layer of retinaUBERON:000178296.81gold quality
trigeminal ganglionUBERON:000167596.01gold quality
medial globus pallidusUBERON:000247795.55gold quality
oocyteCL:000002395.50gold quality
corpus epididymisUBERON:000435995.30gold quality
nephron tubuleUBERON:000123194.68gold quality
globus pallidusUBERON:000187594.64gold quality
dorsal root ganglionUBERON:000004494.26gold quality
secondary oocyteCL:000065594.05gold quality
nucleus accumbensUBERON:000188293.64gold quality
caudate nucleusUBERON:000187393.59gold quality
putamenUBERON:000187493.27gold quality
tibial nerveUBERON:000132392.86gold quality
germinal epithelium of ovaryUBERON:000130492.67gold quality
C1 segment of cervical spinal cordUBERON:000646992.62gold quality
spinal cordUBERON:000224092.50gold quality
buccal mucosa cellCL:000233692.48gold quality
heart right ventricleUBERON:000208091.77gold quality
periodontal ligamentUBERON:000826691.76gold quality
ventricular zoneUBERON:000305391.73gold quality
lateral globus pallidusUBERON:000247691.71gold quality
olfactory bulbUBERON:000226491.64gold quality
amygdalaUBERON:000187691.62gold quality
stromal cell of endometriumCL:000225591.25gold quality
adult mammalian kidneyUBERON:000008291.06gold quality
cranial nerve IIUBERON:000094190.84gold quality
substantia nigraUBERON:000203890.78gold quality
adult organismUBERON:000702390.54gold quality
caput epididymisUBERON:000435890.48gold quality
midbrainUBERON:000189190.37gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-GEOD-135922yes20.03
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

92 targeting GPR137B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4795-3P100.0074.624024
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-511-3P99.9968.851467
HSA-MIR-548N99.9871.944170
HSA-MIR-19A-3P99.9875.332762
HSA-MIR-19B-3P99.9875.442754
HSA-MIR-1213699.9872.815713
HSA-MIR-548AJ-3P99.9673.385345
HSA-MIR-548X-3P99.9673.385345
HSA-MIR-548J-3P99.9472.614881
HSA-MIR-651-3P99.9473.485177
HSA-MIR-548AE-3P99.9372.664867
HSA-MIR-548AH-3P99.9372.544872
HSA-MIR-548AM-3P99.9372.544872
HSA-MIR-548AQ-3P99.9372.664867
HSA-MIR-7-1-3P99.9171.534384
HSA-MIR-7-2-3P99.9171.404394
HSA-MIR-106A-5P99.9073.942683
HSA-MIR-17-5P99.8973.832665
HSA-MIR-153-5P99.8973.866317
HSA-MIR-106B-5P99.8874.722795
HSA-MIR-20A-5P99.8874.762769
HSA-MIR-20B-5P99.8874.012621
HSA-MIR-519D-3P99.8873.972607
HSA-MIR-526B-3P99.8874.062587
HSA-MIR-93-5P99.8873.982606

Literature-anchored findings (GeneRIF, showing 1)

  • PR137B-knockout cells exhibited defective autophagy and an expanded lysosome compartment, similar to Rag-knockout cells. Like zebrafish RagA mutants, GPR137B-mutant zebrafish had upregulated TFEB target gene expression and an expanded lysosome compartment in microglia. (PMID:31036939)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriogpr137bbENSDARG00000077608
danio_reriogpr137baENSDARG00000078448
mus_musculusGpr137bENSMUSG00000021306
rattus_norvegicusGpr137bENSRNOG00000002480

Paralogs (2): GPR137 (ENSG00000173264), GPR137C (ENSG00000180998)

Protein

Protein identifiers

Integral membrane protein GPR137BO60478 (reviewed: O60478)

Alternative names: Transmembrane 7 superfamily member 1 protein

All UniProt accessions (3): O60478, H0Y509, Q5TAF0

UniProt curated annotations — full annotation on UniProt →

Function. Lysosomal integral membrane protein that regulates the localization and activity of mTORC1, a signaling complex promoting cell growth in response to growth factors, energy levels, and amino acids. Interacts with Rag GTPases and increases the lysosomial localization and activity of Rag GTPases and thereby regulates mTORC1 translocation and activity in lysosome. Involved in the regulation of lysosomal morphology and autophagy. Also acts as a negative regulator of osteoclast activity. Involved in interleukin-4-induced M2 macrophage polarization.

Subunit / interactions. Interaction with RRAGA; increases RRAGA recruitment to lysosomes. Interacts with MTOR; this interaction is amino acid sensitive.

Subcellular location. Lysosome membrane.

Tissue specificity. Expressed in kidney, heart, brain and placenta.

Similarity. Belongs to the GPR137 family.

RefSeq proteins (1): NP_003263* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR029723GPR137Family

UniProt features (23 total): topological domain 8, transmembrane region 7, glycosylation site 3, sequence conflict 3, chain 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-O60478-F169.470.26

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (3): 26, 263, 275

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 337 (showing top): GOBP_MYELOID_CELL_DIFFERENTIATION, GOBP_REGULATION_OF_CELL_ACTIVATION, MULLIGHAN_NPM1_SIGNATURE_3_UP, GOBP_REGULATION_OF_AUTOPHAGY, GOBP_NEGATIVE_REGULATION_OF_CELL_DEVELOPMENT, FREAC2_01, GOBP_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION, KAAB_FAILED_HEART_ATRIUM_DN, GOCC_VACUOLAR_MEMBRANE, GOZGIT_ESR1_TARGETS_DN, GOBP_POSITIVE_REGULATION_OF_TOR_SIGNALING, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION, GOBP_REGULATION_OF_GTPASE_ACTIVITY, GOBP_REGULATION_OF_MACROPHAGE_ACTIVATION

GO Biological Process (8): autophagy (GO:0006914), regulation of autophagy (GO:0010506), regulation of macrophage activation (GO:0043030), regulation of GTPase activity (GO:0043087), negative regulation of osteoclast differentiation (GO:0045671), negative regulation of bone resorption (GO:0045779), positive regulation of protein localization to lysosome (GO:0150032), positive regulation of TORC1 signaling (GO:1904263)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (4): lysosomal membrane (GO:0005765), plasma membrane (GO:0005886), membrane (GO:0016020), lysosome (GO:0005764)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
catabolic process1
transmembrane transport1
process utilizing autophagic mechanism1
autophagy1
regulation of catabolic process1
regulation of leukocyte activation1
macrophage activation1
GTPase activity1
regulation of hydrolase activity1
negative regulation of myeloid leukocyte differentiation1
osteoclast differentiation1
regulation of osteoclast differentiation1
regulation of bone resorption1
bone resorption1
negative regulation of bone remodeling1
protein localization to lysosome1
regulation of protein localization to lysosome1
positive regulation of protein localization1
positive regulation of TOR signaling1
TORC1 signaling1
regulation of TORC1 signaling1
binding1
lysosome1
lytic vacuole membrane1
membrane1
cell periphery1
cellular anatomical structure1
lytic vacuole1

Protein interactions and networks

STRING

458 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
GPR137BGPR108Q9NPR9552
GPR137BGPR107Q5VW38520
GPR137BGPR155Q7Z3F1483
GPR137BGPR152Q8TDT2437
GPR137BTM7SF3Q9NS93432
GPR137BGPR82Q96P67413
GPR137BGPR143P51810412
GPR137BCHST8Q9H2A9395
GPR137BGPRC5CQ9NQ84390
GPR137BCOPS5Q92905380
GPR137BSLC26A9Q7LBE3349
GPR137BPAQR9Q6ZVX9346
GPR137BOPN3Q9H1Y3344
GPR137BGPR153Q6NV75338
GPR137BGPR171O14626333

IntAct

20 interactions, top by confidence:

ABTypeScore
GPR137BUSP20psi-mi:“MI:0915”(physical association)0.600
USP20GPR137Bpsi-mi:“MI:0407”(direct interaction)0.600
GPR137BTRIM32psi-mi:“MI:0915”(physical association)0.560
GPR137BDOC2Apsi-mi:“MI:0914”(association)0.530
USP33GPR137Bpsi-mi:“MI:0915”(physical association)0.520
GPR137BGPR137Bpsi-mi:“MI:0915”(physical association)0.400
GPR137BHIF1Apsi-mi:“MI:0915”(physical association)0.400
APPGPR137Bpsi-mi:“MI:0915”(physical association)0.370
GPR137BSMC2psi-mi:“MI:0914”(association)0.350
Mpsi-mi:“MI:0914”(association)0.350
TRIM32GPR137Bpsi-mi:“MI:0915”(physical association)0.000

BioGRID (21): NCAPD2 (Affinity Capture-MS), SMC2 (Affinity Capture-MS), ZYG11B (Affinity Capture-MS), NCAPH (Affinity Capture-MS), DOC2A (Affinity Capture-MS), NCAPG (Affinity Capture-MS), DOC2A (Affinity Capture-MS), NCAPD2 (Affinity Capture-MS), NCAPH (Affinity Capture-MS), NCAPG (Affinity Capture-MS), ZYG11B (Affinity Capture-MS), SMC2 (Affinity Capture-MS), GPR137B (Affinity Capture-RNA), GPR137B (Two-hybrid), TRIM32 (Two-hybrid)

ESM2 similar proteins: A2BGS3, A6NGA9, E7F594, O36364, O60478, O60883, O95800, O95838, P03208, P16849, P31389, P34590, P35367, P49219, Q03613, Q09351, Q09964, Q09965, Q14439, Q16950, Q16951, Q2KI97, Q3U3F9, Q5FVG1, Q5IXF8, Q5UAW9, Q60755, Q64017, Q66615, Q66H29, Q6P7G9, Q6SW98, Q6X632, Q7TSN5, Q7TSN6, Q80W35, Q80WT4, Q8BNQ3, Q8C206, Q8CIM5

Diamond homologs: E7F594, E9Q343, O60478, Q17QQ5, Q6DCW7, Q80ZU9, Q8BNQ3, Q8N3F9, Q96N19

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

61 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic2
Likely pathogenic0
Uncertain significance54
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (2)

Variant IDHGVSClassification
625533GRCh37/hg19 1q42.3-43(chr1:234742890-239475761)Pathogenic
814181GRCh37/hg19 1q42.2-43(chr1:233843930-237971511)x1Pathogenic

SpliceAI

1653 predictions. Top by Δscore:

VariantEffectΔscore
1:236143033:GCAG:Gdonor_gain1.0000
1:236143034:CAGG:Cdonor_loss1.0000
1:236143035:AGGT:Adonor_loss1.0000
1:236143036:GGT:Gdonor_loss1.0000
1:236143037:GTGA:Gdonor_loss1.0000
1:236143038:T:Adonor_loss1.0000
1:236179873:TTCCA:Tacceptor_loss1.0000
1:236179874:TCCAG:Tacceptor_loss1.0000
1:236179875:CCA:Cacceptor_loss1.0000
1:236179876:CA:Cacceptor_loss1.0000
1:236179877:A:ATacceptor_loss1.0000
1:236179877:AG:Aacceptor_gain1.0000
1:236179878:GG:Gacceptor_gain1.0000
1:236183777:GGCA:Gacceptor_gain1.0000
1:236183903:CCTT:Cdonor_gain1.0000
1:236183907:G:GGdonor_gain1.0000
1:236220826:TCTTA:Tdonor_loss1.0000
1:236220827:CTTA:Cdonor_loss1.0000
1:236220828:TTAC:Tdonor_loss1.0000
1:236220829:TA:Tdonor_loss1.0000
1:236220830:A:AGdonor_loss1.0000
1:236220862:T:TAdonor_gain1.0000
1:236220961:TGAGT:Tacceptor_gain1.0000
1:236220962:GAGT:Gacceptor_gain1.0000
1:236220964:GT:Gacceptor_gain1.0000
1:236220966:C:CCacceptor_gain1.0000
1:236143032:CGCAG:Cdonor_gain0.9900
1:236143033:GCAGG:Gdonor_gain0.9900
1:236143037:G:GGdonor_gain0.9900
1:236168700:TTGCA:Tacceptor_loss0.9900

AlphaMissense

2575 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:236183841:T:AW301R0.999
1:236183841:T:CW301R0.999
1:236142884:T:AW88R0.998
1:236142884:T:CW88R0.998
1:236142965:T:AW115R0.998
1:236142965:T:CW115R0.998
1:236142998:T:CF126L0.998
1:236143000:T:AF126L0.998
1:236143000:T:GF126L0.998
1:236178445:A:CS166R0.998
1:236178447:C:AS166R0.998
1:236178447:C:GS166R0.998
1:236178454:T:CF169L0.998
1:236178456:C:AF169L0.998
1:236178456:C:GF169L0.998
1:236178468:T:AN173K0.998
1:236178468:T:GN173K0.998
1:236180008:T:AW273R0.998
1:236180008:T:CW273R0.998
1:236183845:A:TE302V0.998
1:236142984:C:AP121H0.997
1:236178544:G:CD199H0.997
1:236178553:T:CF202L0.997
1:236178555:C:AF202L0.997
1:236178555:C:GF202L0.997
1:236179953:C:AN254K0.997
1:236179953:C:GN254K0.997
1:236180010:G:CW273C0.997
1:236180010:G:TW273C0.997
1:236183820:T:CF294L0.997

dbSNP variants (sampled 300 via entrez): RS1000033289 (1:236196529 T>C), RS1000039683 (1:236188531 G>A,T), RS1000051492 (1:236157771 A>C), RS1000107230 (1:236157575 G>A), RS1000195671 (1:236181252 G>A), RS1000199317 (1:236170766 A>G), RS1000210833 (1:236168282 C>A), RS1000258518 (1:236162435 A>G), RS1000362456 (1:236167844 C>A), RS1000385901 (1:236194590 C>G), RS1000437957 (1:236169927 C>T), RS1000452881 (1:236196932 C>T), RS1000538559 (1:236161497 A>T), RS1000570321 (1:236165444 C>T), RS1000601480 (1:236165699 T>A)

Disease associations

OMIM: gene MIM:604658 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

6 associations (top):

StudyTraitp-value
GCST000883_6Response to antipsychotic treatment in schizophrenia (working memory)5.000000e-07
GCST007094_191Diastolic blood pressure3.000000e-11
GCST007098_34Diastolic blood pressure6.000000e-06
GCST007099_202Systolic blood pressure5.000000e-07
GCST008161_59Waist circumference adjusted for body mass index1.000000e-06
GCST009391_753Metabolite levels3.000000e-06

EFO canonical traits (5, from GWAS)

EFO IDTrait name
EFO:0004335short-term memory
EFO:0006336diastolic blood pressure
EFO:0006335systolic blood pressure
EFO:0007789BMI-adjusted waist circumference
EFO:0010390sphingomyelin 14:0 measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

61 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, increases expression5
Cyclosporineaffects expression, increases expression3
Air Pollutantsdecreases expression, increases abundance, increases expression2
Benzo(a)pyreneaffects methylation2
Phenylmercuric Acetateaffects cotreatment, increases expression2
Testosteroneaffects cotreatment, increases expression2
Tretinoinincreases expression2
Aflatoxin B1affects methylation, decreases methylation2
Particulate Matterdecreases expression, increases abundance, increases expression2
aristolochic acid Idecreases expression1
GSK-J4increases expression1
FR900359increases phosphorylation1
methylmercuric chlorideincreases expression1
triphenyl phosphateaffects expression1
bisphenol Aincreases expression1
quercitrinincreases expression1
terbufosdecreases methylation1
trichostatin Aincreases expression1
beta-lapachoneincreases expression1
tris(1,3-dichloro-2-propyl)phosphateincreases expression1
sodium arseniteincreases expression1
benzo(e)pyreneincreases methylation1
aflatoxin B2increases methylation1
vanadyl sulfatedecreases expression1
CGP 52608affects binding, increases reaction1
2-palmitoylglycerolincreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideincreases expression, affects cotreatment1
ICG 001increases expression1
abrinedecreases expression1
dorsomorphinaffects cotreatment, increases expression1

Cellosaurus cell lines

3 cell lines: 3 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_E0E1Ubigene HeLa GPR137B KOCancer cell lineFemale
CVCL_SQ44HAP1 GPR137B (-) 1Cancer cell lineMale
CVCL_SQ45HAP1 GPR137B (-) 2Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.